Bringing You Closer To Your Next Milestone
We take pride in delivering gold-standard services with high-quality results. Nimble and innovative, SBH Sciences offers customer-centric solutions that have supported over 350 biotech, pharmaceutical, and diagnostic companies. To accelerate your drug discovery journey, we provide rapid turnaround times, cost-effective services, and comprehensive support for projects of all sizes. We build close partnerships through transparency, collaboration, and a commitment to delivering value at every step.
SBH Sciences Expertise
Manufacturing Recombinant Cytokines
a. Our proprietary processes have achieved commercial production of 30 highly purified recombinant cytokines, 33 monoclonal antibodies, 3 monoclonal anti-carbohydrate antibodies, and 8 glycosyltransferase enzymes. SBH produces high-quality research products such as cytokines, monoclonal antibodies, and enzymes for the R&D market.
Providing Biological Assays
a. SBH Sciences excels in the development and validation of cell-based assays to measure the biological activity of cytokines and growth factors. Our services include a diverse range of cell-based disease models, featuring over 370 human cancer cell lines and more than 350 cell-based assays for evaluating cytokine and chemokine activity.
Performing Biomarker Testing
a. SBH has a wide range of experience in analytical development methods and biomarker and biologic drug analysis using our state-of-the-art technologies. We advance complex therapeutic programs, from development during discovery and preclinical phases, to the analysis of clinical samples under Good Laboratory Practice (GLP).
Our 27 Year Legacy Impact
ORF Genetics has been marketing growth factors derived from its barley production platform for close to two decades and has during that time relied on the excellent professional service provided by SBH Sciences in verifying their actions in numerous bioassays. SBH Sciences has been a great and resourceful partner in our journey, and we look forward to continue to strengthen our bonds and our long-term partnership.
As the past Founder and President of Karyopharm Therapeutics, I can share that SBH, and especially Raphael Nir, were a cornerstone in the development of XPOVIO® (selinexor). Raphael was our very first investor, providing important lab resources that enabled us to achieve lead optimization in record time, all while maintaining top-tier science and a remarkably lean budget. Having collaborated with him numerous times since, including at Sporos Bioventures, I'm consistently impressed by his evolving insights into making drug discovery more cost and time-effective. Raphael is truly my parrtner in this field, and I eagerly anticipate our next ventures together
Over the past seven years, SBH Sciences has been an outstanding and cost-effective partner in our journey from concept to IND. In addition to their scientific expertise, they have consistently provided us with an agile and uniquely skilled team—professionals who demonstrated the ability to learn quickly, adapt seamlessly, and tackle even the most complex challenges in the lab environment. Their support was critical as we developed and executed novel, mechanistically intricate oncology assays, enabling the screening of thousands of compounds and generating high-quality in vitro data to support our IND. SBH’s flexibility and commitment to scientific excellence have been invaluable.
My last two biotech startups have developed novel therapeutics with no internal wet labs. How could we do this? By partnering with SBH Sciences, who served as our wet lab, generating accurate data with a remarkably fast turnaround time at a very reasonable price. They have comprehensive capabilities for standard bioassays, as well as novel assay development. I highly recommend them for start-ups looking for an efficient and cost-effective way to generate data!
